GLP-1 enforcement beyond FDA: Justice Department and state attorney general records

As of Nov 15, 2026, this index holds 10 Justice Department or state attorney general actions naming 8 firms over the sale or advertising of GLP-1 drugs: 1 from Justice Department press releases and 9 from state attorney general press releases. Lawsuits, charges, letters and investigative demands are allegations, not findings, and are labeled that way.

Each row is one action read from an official press release. The action type repeats the release’s own wording, and the quote under the table is the release’s sentence naming the firm. A firm’s name links to its page in this index. FDA’s own records on online and telehealth sellers are separate: FDA has posted 125 GLP-1 warning letters to companies it labels telehealth, online sellers or internet pharmacies, and 140 GLP-1 warning letters that name a website (see all FDA warning letters).

Release
Jul 23, 2026U.S. Attorney’s Office, Western District of MichiganSentencingMilestonePurity.comSemaglutide, Tirzepatidejustice.gov
May 6, 2026
reports a settlement from June 2025
Connecticut Attorney GeneralSettlementAdvanced Medical Weight Loss, East Hartford, CTGLP-1 drugs (no ingredient named for this firm)portal.ct.gov
May 6, 2026Connecticut Attorney GeneralSettlement agreementMade-in-ChinaGLP-1 drugs (no ingredient named for this firm)portal.ct.gov
May 6, 2026Connecticut Attorney GeneralSettlementRadiance Medspa, Avon, CTSemaglutide, Tirzepatideportal.ct.gov
Jan 12, 2026Alabama Attorney GeneralSettlementAurora IV and Wellness, Cullman, ALSemaglutide, Tirzepatidealabamaag.gov
Dec 3, 2025Connecticut Attorney GeneralCease and desist letters (allegations, not findings)CT Weight Loss Shot, Danbury, CT; Vigorous 360 Wellness, Brookfield, CT; Radiance Medspa, Avon, CTSemaglutide, Tirzepatideportal.ct.gov
Nov 10, 2025Alabama Attorney GeneralLawsuit and temporary restraining order (allegations, not findings)Aurora IV and Wellness, Cullman, ALSemaglutide, Tirzepatidealabamaag.gov
Aug 5, 2025Connecticut Attorney GeneralSettlementTriggered BrandSemaglutide, Tirzepatideportal.ct.gov
May 21, 2025Connecticut Attorney GeneralCivil investigative demand (an investigation, not a finding)Made In ChinaSemaglutide, Tirzepatideportal.ct.gov
May 21, 2025Connecticut Attorney GeneralLawsuit (allegations, not findings)Triggered Brand, FloridaGLP-1 drugs (no ingredient named for this firm)portal.ct.gov

What each release says

What was searched

This index read every press release on justice.gov’s press release list dated Jan 1, 2026 to Nov 14, 2026 (18,139 releases read through the department’s public press release API) and found 9 releases naming semaglutide, tirzepatide, another GLP-1 drug or a GLP-1 brand name.

State attorney general releases were found by searching for GLP-1, semaglutide and tirzepatide actions and then read on each office’s own website. This is not a complete list of every state’s actions: only the releases in the table were read.

Sources not read

Questions answered from these records

This page lists public regulatory records as published by the issuing agency. A record is not a finding by this site. A warning letter states the agency’s view at the time it was issued; companies may have responded or corrected the issue since. Follow each link for the original document and any close-out letter. Report an error or add a company response.

Sources

Records last pulled Nov 15, 2026. Every entry links to the original public record.